Welcome to our dedicated page for RAC news (Ticker: RAC), a resource for investors and traders seeking the latest updates and insights on RAC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RAC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RAC's position in the market.
Rithm Acquisition Corp has announced the pricing of its initial public offering (IPO) of 20,000,000 units at $10.00 per unit, totaling $200 million. The units will trade on the New York Stock Exchange under 'RAC.U' starting February 27, 2025.
Each unit comprises one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant allows purchasing one Class A share at $11.50. Once separate trading begins, shares and warrants will trade as 'RAC' and 'RAC.WS' respectively.
The IPO, expected to close February 28, 2025, is managed by Citigroup Global Markets, BTIG, and UBS Investment Bank. Underwriters have a 45-day option to purchase up to 3,000,000 additional units to cover over-allotments.
Rithm Acquisition Corp has announced the pricing of its initial public offering (IPO) of 20,000,000 units at $10.00 per unit, totaling $200 million. The units will trade on the New York Stock Exchange under the symbol 'RAC.U' starting February 27, 2025.
Each unit comprises one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant allows holders to purchase one Class A ordinary share at $11.50 per share. Once separate trading begins, the shares and warrants will trade under 'RAC' and 'RAC.WS' respectively.
The offering, expected to close on February 28, 2025, is managed by Citigroup Global Markets, BTIG, and UBS Investment Bank. Underwriters have a 45-day option to purchase up to 3,000,000 additional units to cover over-allotments.
